A: Bottle of “Improved neuralgic tablets, C.T. 169”
marketed by Parke-Davis, similar to one of the formulations included in
Egypt’s list – origin: USA; B: Generic version of Parke-Davis’
formulation “Neuralgic tablets C.C.T. 107” marketed by Jamieson &
Co., similar to one of the formulations included in Egypt’s list –
origin: USA; C: Bottle of “Powdered extract No. 16, Cannabis
(East Indian)” with handwriting reading “Do not dispense, New law,
Oct. 1st 1937” – origin: USA; D: “Indian Cigarettes”
marketed by Grimault Laboratories – origin: India; E: Brochure
on Cannabis published by Parke-Davis in 1908 – origin: USA. (Photos: Ciara Kelley-Cannabis Museum/Michael A. Krawitz
collection, CC BY-NC-SA 4.0).